MedTrace Logo

Vagal Nerve Stimulation for Post COVID Fatigue

NCT05445427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-04-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the impact of vagal nerve stimulation on patients with post COVID syndrome who have fatigue and headache.

Conditions

Interventions

DEVICE

vagal nerve stimulator

Non-invasive vagus nerve stimulator

Sponsors & Collaborators

Principal Investigators

  • Ryan T. Hurt, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-21
Primary Completion
2024-03-28
Completion
2024-03-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05445427 on ClinicalTrials.gov